Upload
beverly-stanley
View
222
Download
4
Tags:
Embed Size (px)
Citation preview
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
3rd Network Steering Committee Meeting
5th Executing Board Meeting
Workshop of Common Understanding
26th-27th September, Helsinki
(-> Agenda)
Dr. Marion Karrasch-Bott
ERA-NET PathoGenoMics - Joint Secretariat
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
1. News
2. Workplan
3. Deliverables and Milestones
4. Financial Summary
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Uptake of the two new Hungarian Partners:
Partner 12: HAS (Hungarian Academy of Sciences)-> NSC member: Prof. Bela Nagy
-> Contact person: Dr. György Schneider
Partner 13: OTKA (Hungarian Scientific Research Fund)
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
PathoGenoMics brochure is now available
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
1. News
2. Workplan
3. Deliverables and Milestones
4. Financial Summary
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
WP 7 development of the admin. framework + Application/ evaluation system
WP 6 working group „training issues“
WP 4 SMEs/industry working group
WP 9 science and society: communication platform
WP 6 development of transnationalresearch consortia
WP 3 development of a „strategic Research Agenda“
12/2005
2005 2006
Agreement about SRA
9/2005
Agreement about admin. framework and appl./ eval. system
4/2005
2007
WP 81st
jointcall WP 8
Project execution
WP 82ndjointcall
Partne-ring Event
2004
9/2004Start
WP 1 + 2
information exchange about the national programmes
Commitment of the partners regarding joint call
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
12/2005
2005 2006 2007
WP 81st
jointcall WP 8
Project execution
2004
9/2004Start
Germany 12/04Spain 01/05
Austria 01/05Slovenia 04/05Finland 05/05France 05/05Israel 07/05
Portugal 08/05
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Expected framework for the first joint call: 4 documents
Announcement:- english version: „skeleton“ for the national announcements; defines research topics, application/evaluation procedure etc.- specifically adapted/supplemented national versions; to be published at the same time (December 2005) in all participating countries
IPR issues: „ Information for applicants for project funding drawing up cooperation agreements on collaborative projects”
Programme/Project management description (internal document)
Guideline for evaluators
√
√
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
1. News
2. Workplan
3. Deliverables and Milestones
4. Financial Summary
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month 24 604812 36
0 24 604812 36
Timetable Deliverables: due dates
D 1.1 D 1.2 D 1.3D 2.1, 2.2, 2.3
D 3.1
D 4.1
D 5.1D 6.1
D 6.2
D 7.1, 7.2, 7.3
D 8.1
D 9.1, 9.2
D 10.1, 10.2
D 2.4
D 3.2
D 3.3D 3.3
D 4.2, 4.3
D 5.2
D 7.4D 8.1
D 8.2 D 8.2
D 8.3, 8.4D 8.3 D 8.4D 8.4
D 9.2 D 9.2 D 9.2 D 9.2 D 9.2
D 10.4D 10.3 D 10.3 D 10.3
D 10.5
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month 24 604812 36
0 24 604812 36
D 1.1
Timetable Deliverables: completion dates
D 1.2 D 1.3D 2.1, 2.2, 2.3
D 3.1
D 6.1D 6.2
D 7.1, 7.2, 7.3
D 8.1
D 9.1, 9.2
D 10.1, 10.2
D 2.4
D 3.2
D 3.3
D 5.2
D 7.4D 8.1
D 8.2 D 8.2
D 8.3, 8.4D 8.3 D 8.4D 8.4
D 9.3 D 9.3 D 9.3 D 9.3
D 10.4D 10.3 D 10.3 D 10.3
D 10.5
D 4.1
D 4.2, 4.3
D 5.1
D 3.3
D 9.3
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month
0 24 604812 36
0 24 604812 36
WP 10: M1 Constituent Assembly
WP 2: M2 Memorandum of Common Understanding
WP 4: M3 Jointly agreed innovation paper
WP 7: M4 Legal and contractual framework
WP 6: M5 European training agenda
WP 4: M6 European research agenda
WP 8: M7a Contracts 1st round
WP 8: M7b Contracts 2nd round
Timetable Milestones
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
1. News
2. Workplan
3. Deliverables and Milestones
4. Financial Summary
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005 2 4 6 8 10
4.000.000
6.000.000
2.000.000
months0
Budget
Cumulative costs per month
and average (€)
Estimated based on the costs of
AT, FI, DE, IL
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005 12 24 36 48 60
2.000.000
Budget and costs (€)
3.000.000
1.000.000
months0
Estimatedbased on the costs
of AT, FI, DE, IL, LV and ES
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
www.pathogenomics-era.net
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month 24 604812 36
0 24 604812 36
D 1.1
Timetable Deliverables: completion dates
D 1.2 D 1.3D 2.1, 2.2, 2.3
D 3.1
D 6.1D 6.2
D 7.1, 7.2, 7.3
D 8.1
D 9.1, 9.2
D 10.1, 10.2
D 2.4
D 3.2
D 3.3
D 5.2
D 7.4D 8.1
D 8.2 D 8.2
D 8.3, 8.4D 8.3 D 8.4D 8.4
D 9.3 D 9.3 D 9.3 D 9.3
D 10.4D 10.3 D 10.3 D 10.3
D 10.5
D 4.1
D 4.2, 4.3
D 5.1
D 3.3
back
D 3.2: Minutes from expert workshop 1 per session (Paris, May 05) Due date: Completion date: MM 13
D 3.3: European Research Agenda 1. published draft 2. final version Due dates: 1. 2. MM 15 Approx. Completion dates: 1. MM 13 ? 2. MM 17 ?
MM 9
MM 11
D 9.3
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month 24 604812 36
0 24 604812 36
D 1.1
Timetable Deliverables: completion dates
D 1.2 D 1.3D 2.1, 2.2, 2.3
D 3.1
D 6.1D 6.2
D 7.1, 7.2, 7.3
D 8.1
D 9.1, 9.2
D 10.1, 10.2
D 2.4
D 3.2
D 3.3
D 5.2
D 7.4D 8.1
D 8.2 D 8.2
D 8.3, 8.4D 8.3 D 8.4D 8.4
D 9.3 D 9.3 D 9.3 D 9.3 D 9.3
D 10.4D 10.3 D 10.3 D 10.3
D 10.5
D 5.1
D 3.3
Deliv.No
Deliverable name Due date (DoW)
Current status
Approx. Comple-tion
D 4.1 Strategy paper “Innovation potentials & perspectives in pathogenomics”
MM 13 1st presentation planned in MM 13
MM 17
D 4.2 Supporting network of innovation partners (PIPs) incl.minutes of 5 annual meetings (MM 15, 24, 36, 48, 60)
MM 15 1st PIP meeting planned for MM 17
MM 17
D 4.3 Web-based innovation market(including multiplication system)
MM 15 Will be delayed due to delay in D 4.1 and 4.2
back
D 4.1
D 4.2, 4.3
WP 4: Stimulating the environment for a wider exploitation and job
creation
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month 24 604812 36
0 24 604812 36
D 1.1
Timetable Deliverables: completion dates
D 1.2 D 1.3D 2.1, 2.2, 2.3
D 3.1
D 6.1D 6.2
D 7.1, 7.2, 7.3
D 8.1
D 9.1, 9.2
D 10.1, 10.2
D 2.4
D 3.2
D 3.3
D 5.2
D 7.4D 8.1
D 8.2 D 8.2
D 8.3, 8.4D 8.3 D 8.4D 8.4
D 9.3 D 9.3 D 9.3 D 9.3
D 10.4D 10.3 D 10.3 D 10.3
D 10.5
D 4.1
D 4.2, 4.3
D 5.1
D 3.3
D 5.1: Partnering workshop in HelsinkiDue date: MM 13
current status:Planned for Feb. 06in collaboration with NoE “EuroPathogenomics”;approx. 2 months after call publication;probably not in Helsinki
back
D 9.3
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month 24 604812 36
0 24 604812 36
D 1.1
Timetable Deliverables: completion dates
D 1.2 D 1.3D 2.1, 2.2, 2.3
D 3.1
D 6.1D 6.2
D 7.1, 7.2, 7.3
D 8.1
D 9.1, 9.2
D 10.1, 10.2
D 2.4
D 3.2
D 3.3
D 5.2
D 7.4D 8.1
D 8.2 D 8.2
D 8.3, 8.4D 8.3 D 8.4D 8.4
D 9.3 D 9.3 D 9.3 D 9.3 D 9.3
D 10.4D 10.3 D 10.3 D 10.3
D 10.5
D 4.1
D 4.2, 4.3
D 5.1
D 3.3
back
D 9.1: IT-based communication and information platform(with media service, archive, event calendars, etc.)Due date: MM 9current status:PathoGenoMics web pages publicly accessible since10th of October 2004. Communication and information platform is being programmed at the moment;will presumably be available in September 2005
D 9.2: Printed information material(e.g. teaching aids, annual reports, brochures, leaflets)Due date: MM 9Current status:First brochure about the PathoGenoMics ERA-NET is available in August 2005
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Month 24 604812 36
0 24 604812 36
D 1.1
Timetable Deliverables: completion dates
D 1.2 D 1.3D 2.1, 2.2, 2.3
D 3.1
D 6.1D 6.2
D 7.1, 7.2, 7.3
D 8.1
D 9.1, 9.2
D 10.1, 10.2
D 2.4
D 3.2
D 3.3
D 5.2
D 7.4D 8.1
D 8.2 D 8.2
D 8.3, 8.4D 8.3 D 8.4D 8.4
D 9.3 D 9.3 D 9.3 D 9.3
D 10.4D 10.3 D 10.3 D 10.3
D 10.5
D 4.1
D 4.2, 4.3
D 5.1
D 3.3
D 9.3
back
D 9.3: On-spot presentations(annually, at special events)Due dates: MM 10, 19, 32, 43, 55)
Completion dates: ?
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Deliv.No Deliverable name Due date (DoW)
Current status Approx. Comple-tion
D 4.1 Strategy paper “Innovation potentials & perspectives in pathogenomics”
MM 13 1st presentation planned in MM13
MM 17
D 4.2 Supporting network of innovation partners (PIPs) incl.minutes of 5 annual meetings (MM 15, 24, 36, 48, 60)
MM 15 1st PIP meeting planned for MM 17
MM 17
D 4.3 Web-based innovation market(including multiplication system)
MM 15 Will be delayed due to delay in D 4.1 and 4.2
back
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Deliv. No
Deliverable name Due date (DoW)
Current status Approx. Comple-tion
Submission to EC
D 5.1 Partnering workshop in Helsinki(about 200 persons, 2 days)
MM 13 Planned for Feb. 06 in collaboration with NoE “EuroPatho-genomics”; approx. 2 months after call publication; probably not in helsinki
MM 17
back
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Deliv.No
Deliverable name Due date (DoW)
Current status Comple-tion
Submission to EC
D 1.1 Agreement on programme data to be collected incl. standard format for data exchange/processing
MM 1 completed MM 3 MM 7(1st Mar 2005)
D. 1.2 Information documents on the national programmes (one per partner)
MM 5 completed MM 7 MM 12(16th Aug 2005)
D 1.3 Interactive Information System on Pathogenomics (IISP)
MM 9 completed MM 2MM 11
MM 12(16th Aug 2005)
D 2.1 Documentations to national programmes in third countries
MM 5 completed MM 7 MM 12(16th Aug 2005)
D 2.2 Compilation of international cooperations between European and third countries
MM 5 completed MM 7 MM 12(16th Aug 2005)
D 2.3 Report “Future trends & challenges in pathogenomics“(as result of a foresight study)
MM 5 completed MM 7 MM 12(16th Aug 2005)
D 2.4 Workshop for common understanding plus related printed information materials (brochures, leaflets)
MM 6 completed MM 8 MM 12(16th Aug 2005)
D 3.1 Minutes from “kick-off” starting meeting
MM 7 completed MM 8 MM 12(16th Aug 2005)
D 3.2 Minutes from expert workshops (one per session)
MM 9 workshop took place 23rd to 25th of May 2005 in Paris; Minutes will be delivered by P5 (MRNT), France, approx. in xx 2005
MM 12
D 3.3 European Research Agenda(1. published draft, 2. final version)
MM 11, 15 MM 11
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Deliv.No
Deliverable name Due date (DoW)
Current status Approx. Comple-tion
Submission to EC
D 4.1 Strategy paper “Innovation potentials & perspectives in pathogenomics”
MM 13 1st presentation planned in MM13
MM 17
D 4.2 Supporting network of innovation partners (PIPs) incl.minutes of 5 annual meetings (MM 15, 24, 36, 48, 60)
MM 15 1st PIP meeting planned for MM 17
MM 17
D 4.3 Web-based innovation market(including multiplication system)
MM 15 Will be delayed due to delay in D 4.1 and 4.2
D 5.1 Partnering workshop in Helsinki(about 200 persons, 2 days)
MM 13 Planned for Feb. 06 with NoE
MM 17
D 5.2 Satellite workshop to 2nd FEMS conference in Spain(July 2006, about 200 persons, 1 day)
MM 23
D 6.1 Summer schools, transnational Ph.D. supervision, joint seminars, and other specific training measures
From MM 13
D 6.2 Integration of PathoGenoMics at the European Researchers Mobility Portal
MM 15
D 7.1 Guidelines for proposers and evaluators;joint evaluation system including administration tools
MM 13 MM 13
D 7.2 Transnational expert/adviser database MM 13
D 7.3 Legal and contractual framework (i.e. contract, cooperation agreement, funding scheme)
MM 13 Agreement on 3rd NSC meeting planned
MM 13
D 7.4 Transnational task force of programme managers from MM 14 See D 7.3 MM 13
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Deliv.No
Deliverable name Due date (DoW)
Current status Approx. Comple-tion
D 8.1 Publication of 2 synchronised, specifictransnational calls
MM 16, 28 Publication of the first joint call scheduled for December 2005
MM 16
D 8.2 2 evaluation sessions incl. priority lists
MM 22, 34 Deadline for proposal submission scheduled for April 2006, evaluation will take place April to June 2006
MM 22
D 8.3 Selected proposals and funding contracts
MM 24, 36 Funding decision scheduled for July 2006 MM 3
D 8.4 Periodical project reports (annually)
MM 36, 48,60
D 9.1 IT-based communication and information platform(with media service, archive, event calendars, etc.)
MM 9 PathoGenoMics web pages publicly accessible since 10th of October 2004.Communication and information platform is programmed at the moment; will presumably be available in September 2005
D 9.2 Printed information materials(i.e. teaching aids, annual reports, brochures, leaflets)
MM 9 First brochure about the PathoGenoMics ERA-NET is available in August 2005
D 9.3 On-spot presentations(annually, at special events)
MM 10, 19, 32, 43, 55
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Deliv.No
Deliverable name
Due date
Current status Comple-tion
Submission to EC
D 10.1 Joint Secretariat MM 4 Joint Secretariat was established on 1st of September 2004.
MM 1 MM 3(15th Nov 2004)
D 10.2 Electronic Management and Information System
MM 4 PathoGenoMics web pages publicly accessible since 10th of October 2004.Web-based management- and information tool available since 25th of February, 2005
MM 2MM 6
MM 7(1st Mar 2005)
D 10.3 Consortium management reporting(progress and financial reports, audit certificates)
MM 12, 24, 36, 48, 60
Consortium management reporting submitted 11/04, 03/05, 08/05
Financial report and audit certificates due in MM 18, 36 and 60
MM 2, MM 7, MM 12
D 10.4 Consortium agreement
MM 1 The signed Agreements were returned to the Coordinator between November 2004 and February 2005 (last Agreement arrived on 21st February at the Coordinator) (except Hungary)
MM 6 MM 7(1st Mar 2005)
D 10.5 NSC and EB meetings incl. quarterly circulars
MM 1, 3, 6, 9, 12, ..., 60
The 1st NSC meeting and the 1st EB meeting: 13th – 15th October 2004 in BerlinThe 2nd EB meeting: 20th January in Bonn, Germany The 3rd EB/ 2nd NSC meeting: 7th/8th of April in Bonn, GermanyThe 4th EB meeting: 27th/28th of June in Vienna, Austria The 5th EB/ 3rd NSC meeting: 26th/27th of September in Helsinki, Finland
MM 2
MM 5
MM 8
MM 10
MM 3(15th Nov 2004)MM 7(1st Mar 2005)MM 12(16th Aug 2005)MM 12(16th Aug 2005)
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Year DueMonth
Number
Specification Current status Approx. completion
Submission to EC
1 MM 1 M 1 Constituent Assembly to establish project bodies
Constituent Assembly held on 13th to 15th October 2004 in Berlin, Project Bodies have been established
CompletedMM 2
MM 3(15th Nov 2004)
MM 6 M 2 Memorandum of Common Understanding
Completed on the NSC/EB meeting on the 7th and 8th April 2005 in Bonn
CompletedMM 8
MM 12(16th August 2005)
2 MM 13
M 3 jointly agreed Innovation Strategy Paper
MM 18
MM 13
M 4 jointly agreed Legal & Contractual Framework for Joint Calls
MM 13
MM 13
M 5 jointly agreed European Training Agenda
MM 13
MM 15
M 6 Jointly agreed European Research Agenda
MM 13
MM 24
M 7a Contracts, 1st round of Joint Calls
MM 22
3 MM 36
M 7b Contracts, 2nd round of Joint Calls
MM 34
Milestones
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
MONDAY, September 26, 2005 Conference Centre Paasitorni, meeting room “Juho Rissanen” (2nd floor)
9:30-9.40 Welcome
9.40-10.00 The current ERA-Net status and the planning of FP 7 (Giorgio Clarotti, Scientific Officer, European Commission)
10:00-10:10 ERA-NET PathoGenoMics: Current status. (Marion Karrasch, ERA-NET PathoGenoMics Secretariat)
10:10-10:30 A summary of the expert workshop on the European Research Agenda (WP 3) (Philippe Glaser, Instutut Pasteur, France)
10:30-10:50 Coffee
10:50-11:10 General information on the Network of PathoGenoMics innovation partners (WP 4) (Kathleen Victoir, Institut Pasteur, France)
11:10-11:40 A summary of the call text and the IPR issues. Decisions on the open parts of the call text (dates, other)
11:40-12:00 Decisions on the call text and the IPR issues
– Memorandum of common understanding
12:00-13:00 Lunch
13:00-14:30 Implementation of the joint call:
- Evaluation criteria/guidelines of proposals submitted
- Internal programme management procedure
- Nomination of the Scientific Advisory Board members for the evaluation of the proposals
- Discussion on the application forms
14:30-14:50 Coffee
14:50-17:00 Implementation of the joint call (continues)
Agenda September 26-27, 2005 Helsinki, Finland
.
back
ERA-NET PathoGenoMics
M. Karrasch, FZJ26.09.2005
Agenda September 26-27, 2005 Helsinki, Finland
TUESDAY, September 27, 2005 Conference Centre Paasitorni, meeting room “Juho Rissanen” All participants are welcome to attend the NSC and the EB meetings
3rd Network Steering Committee (NSC) meeting
9:00-9:40 - Chair for the NSC for the 2nd year - Preparation of the meeting to be held in Jerusalem in the spring 2006 - Other issues
5th Executing Board (EB) meeting
9:40-10:30 - Administrative issues: financial status
- The current status of the on-going activities WP5: Preparation of the Partnering Event
WP6: Training and mobility
WP9: Science and society - Other issues
10:30-10.45 Coffee
10.45-12.15 EB Meeting (continues)
12:15-13:00 Lunch break
13:00-14:00 EB Meeting (continues, if needed)